SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108. A total of 90 filers reported holding SPECTRUM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $98,285 | -23.8% | 76,190 | -24.9% | 0.00% | – |
Q4 2021 | $129,000 | -40.3% | 101,415 | +2.6% | 0.00% | – |
Q3 2021 | $216,000 | -37.2% | 98,893 | +7.8% | 0.00% | – |
Q2 2021 | $344,000 | +19.9% | 91,715 | +4.0% | 0.00% | – |
Q1 2021 | $287,000 | -5.6% | 88,157 | -1.1% | 0.00% | – |
Q4 2020 | $304,000 | -9.0% | 89,149 | +8.9% | 0.00% | – |
Q3 2020 | $334,000 | +50.5% | 81,884 | +13.5% | 0.00% | – |
Q2 2020 | $222,000 | +29.8% | 72,137 | -1.7% | 0.00% | – |
Q1 2020 | $171,000 | -30.8% | 73,406 | +8.0% | 0.00% | – |
Q4 2019 | $247,000 | -60.5% | 67,982 | -3.8% | 0.00% | -100.0% |
Q3 2019 | $626,000 | +2.8% | 70,674 | -0.1% | 0.00% | 0.0% |
Q2 2019 | $609,000 | -14.3% | 70,714 | +6.3% | 0.00% | 0.0% |
Q1 2019 | $711,000 | +31.4% | 66,514 | +7.5% | 0.00% | 0.0% |
Q4 2018 | $541,000 | -51.4% | 61,881 | -6.6% | 0.00% | 0.0% |
Q3 2018 | $1,113,000 | -28.1% | 66,246 | -10.3% | 0.00% | -50.0% |
Q2 2018 | $1,549,000 | +48.4% | 73,892 | +13.8% | 0.00% | +100.0% |
Q1 2018 | $1,044,000 | -16.9% | 64,939 | -2.1% | 0.00% | 0.0% |
Q4 2017 | $1,257,000 | +48.9% | 66,341 | +10.7% | 0.00% | 0.0% |
Q3 2017 | $844,000 | +82.7% | 59,945 | -3.4% | 0.00% | 0.0% |
Q2 2017 | $462,000 | +12.4% | 62,070 | -1.9% | 0.00% | 0.0% |
Q1 2017 | $411,000 | +64.4% | 63,299 | +12.5% | 0.00% | – |
Q4 2016 | $250,000 | +11.1% | 56,263 | +16.9% | 0.00% | – |
Q3 2016 | $225,000 | -27.9% | 48,141 | +1.6% | 0.00% | – |
Q2 2016 | $312,000 | +7.6% | 47,402 | +2.8% | 0.00% | – |
Q1 2016 | $290,000 | +5.5% | 46,089 | +1.0% | 0.00% | – |
Q4 2015 | $275,000 | +2.6% | 45,641 | +1.7% | 0.00% | – |
Q3 2015 | $268,000 | -11.3% | 44,884 | +1.5% | 0.00% | – |
Q2 2015 | $302,000 | +10.2% | 44,218 | -2.2% | 0.00% | – |
Q1 2015 | $274,000 | -10.2% | 45,224 | +2.8% | 0.00% | – |
Q4 2014 | $305,000 | -14.1% | 44,006 | +0.7% | 0.00% | -100.0% |
Q3 2014 | $355,000 | +2.9% | 43,695 | +2.9% | 0.00% | 0.0% |
Q2 2014 | $345,000 | -10.6% | 42,461 | -13.6% | 0.00% | 0.0% |
Q1 2014 | $386,000 | -11.5% | 49,162 | -0.3% | 0.00% | 0.0% |
Q4 2013 | $436,000 | +9.8% | 49,311 | +4.1% | 0.00% | 0.0% |
Q3 2013 | $397,000 | +9.1% | 47,347 | -3.0% | 0.00% | 0.0% |
Q2 2013 | $364,000 | – | 48,796 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 6,963,756 | $145,960,000 | 9.42% |
Avoro Capital Advisors LLC | 3,419,818 | $71,679,000 | 2.76% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 300,000 | $6,285,000 | 2.41% |
Cormorant Asset Management, LP | 1,200,000 | $25,152,000 | 1.86% |
Sio Capital Management, LLC | 143,550 | $3,009,000 | 1.66% |
ASHFORD CAPITAL MANAGEMENT INC | 425,702 | $8,923,000 | 1.18% |
PURA VIDA INVESTMENTS, LLC | 130,700 | $2,739,000 | 1.10% |
Sonora Investment Management, LLC | 298,967 | $6,266,000 | 0.97% |
PURA VIDA INVESTMENTS, LLC | 100,000 | $2,096,000 | 0.84% |
J. Goldman & Co LP | 694,338 | $14,553,000 | 0.75% |